MRI T1 relaxation time for evaluating early complete response to neoadjuvant treatment in rectal cancer: measurement at six weeks – a protocol article
Open Access
- 30 July 2025
- journal article
- Published by SAGE Publications in Acta Radiologica Open
- Vol. 14 (7)
Abstract
Background: Management of rectal cancer requires accurate staging and treatment. Neoadjuvant chemoradiotherapy offers tumour size reduction and mitigation of the risk of local relapse. Patients with complete response to neoadjuvant treatment can be enclosed in watchful waiting (WW). Recent studies have explored magnetic resonance imaging (MRI) T1 relaxation time (T1RT) as a predictive biomarker for treatment response in rectal cancer. Preliminary findings indicate that lower T1RT correlates with pathologic complete response. However, inclusion of patients in WW remains unexplored. Purpose: This prospective study aims to investigate T1RT 6 weeks after neoadjuvant treatment and the ability to determine complete response. Material and methods: MRI scans are conducted on a 1.5 T MRI-unit. T1RT is measured at time of diagnosis and 6 weeks after neoadjuvant treatment. Experienced radiologists analyse T1RT using specialised software. Treatment decisions are made in multidisciplinary team conferences based on tumour staging. Endpoints include tumour visibility on MRI and endoscopy, along with histopathological analysis of surgical specimens. Statistical methods include t test and receiver operating characteristic curves. Sample size calculations showed we must enrol 76 participants to achieve a statistical power of 80% with an α = 0.05. Results: Data analysis begins in winter 2025. Results are planned to be submitted in spring 2026. Conclusion: The implications of this study extend to the potential refinement of treatment strategies, offering patients the prospect of improved outcomes and the potential avoidance of surgery-associated risks. We expect to find a lower relaxation time in fibrotic tissue compared to non-responsive cancerous tissue after 6 weeks.Keywords
This publication has 17 references indexed in Scilit:
- The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal CancerClinical Oncology, 2022
- Native T1 mapping of the breast in MRI to differentiate fibroadenomas from benign phyllodes tumors: a preliminary studyMagnetic Resonance Materials in Physics, Biology and Medicine, 2021
- T1 relaxation times and MR elastography-derived stiffness: new potential imaging biomarkers for the assessment of chronic pancreatitisAbdominal Radiology, 2021
- Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiationEuropean Radiology, 2020
- T1 reactivity as an imaging biomarker in myocardial tissue characterization discriminating normal, ischemic and infarcted myocardiumThe International Journal of Cardiovascular Imaging, 2019
- Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial reviewInsights into Imaging, 2019
- Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meetingEuropean Radiology, 2017
- High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational studyThe Lancet Oncology, 2015
- Quantitative magnetic resonance imaging in rectal carcinomaBritish Journal of Radiology, 1987
- Index for rating diagnostic testsCancer, 1950